$EWTX 3 SEC Filings

Filed On	Filing
24 Nov 2025	Form 3: Martin Christopher Nathan, Director No securities owned
13 Nov 2025	Form 3: Nofi Michael, Chief Financial Officer No securities owned
23 Jan 2025	Form 3: Blaustein Robert, Chief Development Officer No securities owned
07 May 2024	Form 3: Morris Arlene, Director No securities owned
07 Mar 2023	Form 3: Fox Jonathan C, Director No securities owned
22 Dec 2022	Form 3: Semigran Marc, Chief Development Officer No securities owned
04 May 2021	Form 3: Donovan Joanne M., CMO No securities owned
25 Mar 2021	Form 3: Thompson Peter A., Director Holds 316,920 shares of Common Stock
25 Mar 2021	Form 3: Russell Alan J, Director Holds 264,100 shares of Common Stock
25 Mar 2021	Form 3: Root Jonathan D, Director
25 Mar 2021	Form 3: Orbimed Advisors Llc, Director and 2 others Holds 316,920 shares of Common Stock
25 Mar 2021	Form 3: Moore John R, General Counsel
25 Mar 2021	Form 3: Koch Kevin, Director Holds 259,554 shares of Common Stock
25 Mar 2021	Form 3: Harrison Kenneth Ph.D., Director No securities owned
25 Mar 2021	Form 3: Edris Badreddin, Director Holds 19,820 shares of Common Stock
25 Mar 2021	Form 3: Edris Badreddin, Director Holds 19,820 shares of Common Stock
25 Mar 2021	Form 3: Derakhshan Behrad, Chief Business Officer
25 Mar 2021	Form 3: Carruthers R Michael, Chief Financial Officer
25 Mar 2021	Form 3: Brege Laura, Director
25 Mar 2021	Form 3: Wellington Biomedical Innovation Master Investors (Cayman) I L.p., 10% owner

Comments